Use of genetically engineered stem cells for glioma therapy

Por NAMBA, HIROKI, KAWAJI, HIROSHI, YAMASAKI, TOMOHIRO
Publicado no Oncol Lett (2016)

Interferon-β and temozolomide combination therapy for temozolomide monotherapy-refractory malignant gliomas

Por KAWAJI, HIROSHI, TOKUYAMA, TSUTOMU, YAMASAKI, TOMOHIRO, AMANO, SHINJI, SAKAI, NAOTO, NAMBA, HIROKI
Publicado no Mol Clin Oncol (2015)

Genetically Engineered Multilineage-Differentiating Stress-Enduring Cells as Cellular Vehicles against Malignant Gliomas

Por Yamasaki, Tomohiro, Wakao, Shohei, Kawaji, Hiroshi, Koizumi, Shinichiro, Sameshima, Tetsuro, Dezawa, Mari, Namba, Hiroki
Publicado no Mol Ther Oncolytics (2017)

Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia

Por Yamasaki, Tomohiro, Iwashima, Yoshio, Jesmin, Subrina, Ohta, Yuko, Kusunoki, Hiroshi, Hayashi, Shin-ichiro, Horio, Takeshi, Kawano, Yuhei
Publicado em 2014

Primary Neurolymphomatosis of the Lower Cranial Nerves Presenting as Dysphagia and Hoarseness: A Case Report

Por Sakai, Naoto, Ito-Yamashita, Tae, Takahashi, Goro, Baba, Satoshi, Koizumi, Shinichiro, Yamasaki, Tomohiro, Tokuyama, Tsutomu, Namba, Hiroki
Publicado em 2014

ET-67 SUICIDE GENE THERAPY FOR GLIOMA USING MULTILINEAGE-DEFFERENTIATING STRESS ENDURING (MUSE) CELLS

Por Yamasaki, Tomohiro, Wakao, Shohei, Kawaji, Hiroshi, Suzuki, Tomo, Kamio, Yoshinobu, Amano, Shinji, Sameshima, Tetsuro, Sakai, Naoto, Tokuyama, Tsutomu, Dezawa, Mari, Namba, Hiroki
Publicado em 2014